Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yizhi Peng, Sheng Yin & Min Wang. (2021) Extracellular vesicles of bacteria as potential targets for immune interventions. Human Vaccines & Immunotherapeutics 17:3, pages 897-903.
Read now
Read now
Chukiat Sirivichayakul, Pornthep Chanthavanich, Kriengsak Limkittikul, Claire-Anne Siegrist, Wassana Wijagkanalan, Pailinrut Chinwangso, Jean Petre, Pham Hong Thai, Mukesh Chauhan & Simonetta Viviani. (2017) Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults. Human Vaccines & Immunotherapeutics 13:1, pages 136-143.
Read now
Read now
Nicole Guiso & Carl Heinz Wirsing von König. (2016) Surveillance of pertussis: methods and implementation. Expert Review of Anti-infective Therapy 14:7, pages 657-667.
Read now
Read now
Christian Herzog. (2015) Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection. Expert Review of Vaccines 14:8, pages 1065-1072.
Read now
Read now
Jan T Poolman. (2014) Shortcomings of pertussis vaccines: why we need a third generation vaccine. Expert Review of Vaccines 13:10, pages 1159-1162.
Read now
Read now
Jan T Poolman. (2014) Pertussis vaccines. Expert Review of Vaccines 13:9, pages 1067-1069.
Read now
Read now
Articles from other publishers (37)
Jasmine R Marcelin, Audrey Pettifor, Holly Janes, Elizabeth R Brown, James G Kublin & Kathryn E Stephenson. (2022) COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective. Open Forum Infectious Diseases 9:5.
Crossref
Crossref
Nevio Cimolai. (2022) Non-primate animal models for pertussis: back to the drawing board?. Applied Microbiology and Biotechnology 106:4, pages 1383-1398.
Crossref
Crossref
Nicole Guiso, Benoit Soubeyrand & Denis Macina. (2022)
Can vaccines control bacterial virulence and pathogenicity?
Bordetella pertussis
: the advantage of fitness over virulence
. Evolution, Medicine, and Public Health 10:1, pages 363-370.
Crossref
Crossref
Jory A. Goldsmith, Andrea M. DiVenere, Jennifer A. Maynard & Jason S. McLellan. (2021) Structural basis for antibody binding to adenylate cyclase toxin reveals RTX linkers as neutralization-sensitive epitopes. PLOS Pathogens 17:9, pages e1009920.
Crossref
Crossref
Daniela Leite, Carlos Henrique Camargo, Suely Sanae Kashino, Ricardo Polatto, Luciano Moura Martins, Juliana Cristina Pereira, Lucia Pawloski, Maria Lucia Tondella, Rosangela Siqueira de Oliveira & Lourdes Rehder de Andrade Vaz de Lima. (2021) Prevalence and characterization of pertactin deficient Bordetella pertussis strains in Brazil, a whole-cell vaccine country. Vaccine: X 8, pages 100103.
Crossref
Crossref
Kathrin U. Jansen, William C. Gruber, Raphael Simon, James Wassil & Annaliesa S. Anderson. 2021. Sustainable Agriculture Reviews 49. Sustainable Agriculture Reviews 49
347
430
.
Jakub Novák, David Jurnečka, Irena Linhartová, Jana Holubová, Ondřej Staněk, Daniel Štipl, Ana Dienstbier, Branislav Večerek, Nayara Azevedo, Jan Provazník, Vladimír Beneš & Peter Šebo. (2020)
A Mutation Upstream of the
rplN-rpsD
Ribosomal Operon Downregulates Bordetella pertussis Virulence Factor Production without Compromising Bacterial Survival within Human Macrophages
. mSystems 5:6.
Crossref
Crossref
A. P. Cherdantsev, E. V. Prutskova & M. P. Kostinov. (2020) New features of pertussis vaccination. CHILDREN INFECTIONS 19:2, pages 58-63.
Crossref
Crossref
I. Mack, T.E. Erlanger, P. Lang, P. Sinniger, D. Perisa & U. Heininger. (2020) Dose-dependent effectiveness of acellular pertussis vaccine in infants: A population-based case-control study. Vaccine 38:6, pages 1444-1449.
Crossref
Crossref
Francisco Carriquiriborde, Victoria Regidor, Pablo M. Aispuro, Gabrielli Magali, Erika Bartel, Daniela Bottero & Daniela Hozbor. (2019)
Rare Detection of
Bordetella pertussis
Pertactin-Deficient Strains in Argentina
. Emerging Infectious Diseases 25:11, pages 2048-2054.
Crossref
Crossref
Usa Thisyakorn, Terapong Tantawichien, Chule Thisyakorn & Philippe Buchy. (2019) Pertussis in the Association of Southeast Asian Nations: epidemiology and challenges. International Journal of Infectious Diseases 87, pages 75-83.
Crossref
Crossref
María Eugenia Zurita, Mieszko M. Wilk, Francisco Carriquiriborde, Erika Bartel, Griselda Moreno, Alicja Misiak, Kingston H. G. Mills & Daniela Hozbor. (2019) A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella pertussis, Including Pertactin Deficient Strains. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Crossref
Alex-Mikael Barkoff, Jussi Mertsola, Denis Pierard, Tine Dalby, Silje Vermedal Hoegh, Sophie Guillot, Paola Stefanelli, Marjolein van Gent, Guy Berbers, Didrik Vestrheim, Margrethe Greve-Isdahl, Lena Wehlin, Margaretha Ljungman, Norman K. Fry, Kevin Markey & Qiushui He. (2019) Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Eurosurveillance 24:7.
Crossref
Crossref
Carolina Argondizo-Correia, Ana Kelly Sousa Rodrigues & Cyro Alves de Brito. (2019)
Neonatal Immunity to
Bordetella pertussis
Infection and Current Prevention Strategies
. Journal of Immunology Research 2019, pages 1-10.
Crossref
Crossref
Ikram Ben Fraj, Amel Kechrid, Sophie Guillot, Valérie Bouchez, Sylvain Brisse, Nicole Guiso & Hanen Smaoui. (2019) Pertussis epidemiology in Tunisian infants and children and characterization of Bordetella pertussis isolates: results of a 9-year surveillance study, 2007 to 2016. Journal of Medical Microbiology 68:2, pages 241-247.
Crossref
Crossref
Anne Marie Queenan, David J. Dowling, Wing Ki Cheng, Kellen Faé, Jeffrey Fernandez, Peter J. Flynn, Sweta Joshi, Spencer E. Brightman, Juan Ramirez, Jan Serroyen, Selma Wiertsema, Alexandre Fortanier, Germie van den Dobbelsteen, Ofer Levy & Jan Poolman. (2019) Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. Vaccine 37:1, pages 80-89.
Crossref
Crossref
Nicole Guiso & Fabien Taieb. 2019. Pertussis Infection and Vaccines. Pertussis Infection and Vaccines
137
149
.
Paola Stefanelli. 2019. Pertussis Infection and Vaccines. Pertussis Infection and Vaccines
127
136
.
Fatemah Sadeghpour Heravi, Vajihe Sadat Nikbin, Masomeh Nakhost Lotfi, Pouran Badiri, Nazanin Jannesar Ahmadi, Seyed Mohsen Zahraei & Fereshteh Shahcheraghi. (2018) Strain variation and antigenic divergence among Bordetella pertussis circulating strains isolated from patients in Iran. European Journal of Clinical Microbiology & Infectious Diseases 37:10, pages 1893-1900.
Crossref
Crossref
Giovanni Gabutti, Armando Stefanati & Parvanè Kuhdari. 2018. Pertussis - Disease, Control and Challenges. Pertussis - Disease, Control and Challenges.
Christiane S. Eberhardt & Claire-Anne Siegrist. (2017) What Is Wrong with Pertussis Vaccine Immunity?. Cold Spring Harbor Perspectives in Biology 9:12, pages a029629.
Crossref
Crossref
Nicole Guiso, Corinne Levy, Olivier Romain, Sophie Guillot, Andreas Werner, Marie Charlotte Rondeau, Stéphane Béchet & Robert Cohen. (2017) Whooping cough surveillance in France in pediatric private practice in 2006–2015. Vaccine 35:45, pages 6083-6088.
Crossref
Crossref
Waldely de Oliveira Dias, Ana Fabíola R.O. Prestes, Priscila S. Cunegundes, Eliane P. Silva & Isaias Raw. 2017. Vaccines. Vaccines.
Ewa Mosiej, Katarzyna Krysztopa-Grzybowska, Maciej Polak, Marta Prygiel & Anna Lutyńska. (2017) Multi-locus variable-number tandem repeat analysis of Bordetella pertussis isolates circulating in Poland in the period 1959–2013. Journal of Medical Microbiology 66:6, pages 753-761.
Crossref
Crossref
David A. Kennedy & Andrew F. Read. (2017) Why does drug resistance readily evolve but vaccine resistance does not?. Proceedings of the Royal Society B: Biological Sciences 284:1851, pages 20162562.
Crossref
Crossref
Elise S. Hovingh, Bryan van den Broek & Ilse Jongerius. (2016) Hijacking Complement Regulatory Proteins for Bacterial Immune Evasion. Frontiers in Microbiology 7.
Crossref
Crossref
Rubén Solano, Josefa Masa-Calles, Zacarías Garib, Patricia Grullón, Sandy L. Santiago, Altagracia Brache, Ángela Domínguez & Joan A. Caylà. (2016) Epidemiology of pertussis in two Ibero-American countries with different vaccination policies: lessons derived from different surveillance systems. BMC Public Health 16:1.
Crossref
Crossref
Iraj Sedighi, Abdollah Karimi & Ali Amanati. (2016) Old Disease and New Challenges: Major Obstacles of Current Strategies in the Prevention of Pertussis. Iranian Journal of Pediatrics 26:4.
Crossref
Crossref
Katie L. Sealey, Thomas Belcher & Andrew Preston. (2016) Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence. Infection, Genetics and Evolution 40, pages 136-143.
Crossref
Crossref
Pamela K. Cassiday, Tami H. Skoff, Selina Jawahir & M. Lucia Tondella. (2016)
Changes in Predominance of Pulsed-Field Gel Electrophoresis Profiles of
Bordetella pertussis
Isolates, United States, 2000–2012
. Emerging Infectious Diseases 22:3, pages 442-448.
Crossref
Crossref
Scott A. Halperin. 2016. The Vaccine Book. The Vaccine Book
205
221
.
María Emilia Gaillard, Daniela Bottero, Griselda Moreno, Martin Rumbo & Daniela Hozbor. (2015) Strategies and new developments to control pertussis, an actual health problem: Graphical Abstract Figure.. Pathogens and Disease 73:8, pages ftv059.
Crossref
Crossref
Valérie Bouchez & Nicole Guiso. (2015)
Bordetella pertussis
,
B. parapertussis
, vaccines and cycles of whooping cough
. Pathogens and Disease 73:7, pages ftv055.
Crossref
Crossref
Valérie Bouchez, Nicolas Hegerle, Francesco Strati, Elisabeth Njamkepo & Nicole Guiso. (2015) New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates. Vaccines 3:3, pages 751-770.
Crossref
Crossref
Nevine El Khatib, Agnes Ferroni, Muriel Le Bourgeois, Frederique Chedevergne, Marlene Clairicia, Helene Avril, Nicole Guiso & I. Sermet-Gaudelus. (2015) Persistent Bordetella bronchiseptica infection in a child with cystic fibrosis: Relationship to bacterial phenotype. Journal of Cystic Fibrosis 14:5, pages E13-E15.
Crossref
Crossref
Jason M Warfel & Kathryn M Edwards. (2015) Pertussis vaccines and the challenge of inducing durable immunity. Current Opinion in Immunology 35, pages 48-54.
Crossref
Crossref
M. van Gent, C. J. Heuvelman, H. G. van der Heide, H. O. Hallander, A. Advani, N. Guiso, C. H. Wirsing von Kőnig, D. F. Vestrheim, T. Dalby, N. K. Fry, D. Pierard, L. Detemmerman, J. Zavadilova, K. Fabianova, C. Logan, A. Habington, M. Byrne, A. Lutyńska, E. Mosiej, C. Pelaz, K. Gröndahl-Yli-Hannuksela, A. M. Barkoff, J. Mertsola, A. Economopoulou, Q. He & F. R. Mooi. (2014) Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998–2012. European Journal of Clinical Microbiology & Infectious Diseases 34:4, pages 821-830.
Crossref
Crossref